Top Stories in Cardiology: December 2019
In what’s become an annual tradition, the TCTMD reporters chose their favorite stories of 2019.
In what’s become an annual tradition, the TCTMD reporters chose their favorite stories of 2019.
In dialysis-dependent patients, those on denosumab for fracture risk had a 36% higher MACE rate than those on bisphosphonates.
Where do we start? Roxana Mehran hears from Noel Bairey Merz and Stefan Blankenberg.
Why do some heart transplants fail in pediatric patients? Shahnawaz Amdani, MD, shares the main risk factors for repeat rejection.
With the pandemic having worsened burnout and intent to leave, the authors say keeping and supporting the workforce is critical.
Clinicians and patients alike have lost homes and possessions, but cardiovascular care in Los Angeles remains robust.
The agency says the strategy would help millions quit and prevent 4.3 million tobacco-related deaths by the end of the century.
The aim is to make it easier for consumers to determine how much saturated fat, sodium, and added sugar are inside.
The aim is to make it easier for consumers to determine how much saturated fat, sodium, and added sugar are inside.
Public comments will be accepted for 30 days. A final coverage decision is expected in October 2025.
Fitness doesn’t make people immune to atherosclerosis, but what to do with the finding in asymptomatic patients is uncertain.